TAT-Braftide is a peptide inhibitor designed to block the dimerization of BRAF, thereby inhibiting its kinase activity. The destruction of BRAF dimer by TAT-Braftide makes BRAF protein more susceptible to proteasome degradation, directly inhibits the activity of BRAF kinase, and reduces the activation of MAPK signaling pathway. Tat-braftide can be used for the role of RAF kinase in MAPK signaling pathway and for the study of BRAF mutant cancers[1].
Molecular Weight:
2992.56
Purity:
99.52
Formula:
C128H227N51O30S
Target:
Raf
Application Notes:
Peptides
* VAT and and shipping costs not included. Errors and price changes excepted
